(Q34053771)

30 July 2017

1 reference

title

Clinical pharmacokinetics of teicoplanin. (English)

1 reference

30 July 2017

1 reference

Wilson AP

1

1 reference

30 July 2017

publication date

1 September 2000

1 reference

Clinical Pharmacokinetics

30 July 2017

published in

1 reference

30 July 2017

volume

39

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

167-183

1 reference

Elimination of drugs by the new polyamide hemofilter FH77H during various in vitro conditions.

30 July 2017

cites work

1 reference

12 December 2020

Population pharmacokinetic study of teicoplanin in severely neutropenic patients

1 reference

12 December 2020

Evaluation of a novel fluorescence polarization immunoassay for teicoplanin

1 reference

12 December 2020

Determination of teicoplanin in plasma using microbore high-performance liquid chromatography and injection-generated gradients

1 reference

12 December 2020

Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.

1 reference

12 December 2020

Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers

1 reference

12 December 2020

Effect of morphine or phenobarbital on teicoplanin elimination pharmacokinetics

1 reference

12 December 2020

Clinical pharmacokinetics of teicoplanin and aminophylline during cotreatment with both medicaments

1 reference

12 December 2020

Renal tolerability of teicoplanin in a case of neonatal overdose

1 reference

12 December 2020

Physical and chemical compatibility of intravenous ciprofloxacin with other drugs

1 reference

12 December 2020

Teicoplanin in the prevention of infection in total hip replacement.

1 reference

12 December 2020

Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome

1 reference

12 December 2020

The pharmacokinetics of teicoplanin in infants and children

1 reference

12 December 2020

Intravitreal penetration of teicoplanin

1 reference

12 December 2020

Use of teicoplanin in preterm neonates with staphylococcal late-onset neonatal sepsis

1 reference

12 December 2020

Teicoplanin pharmacokinetics in pediatric patients

1 reference

12 December 2020

Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections

1 reference

12 December 2020

Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in hemodialysis patients

1 reference

12 December 2020

Concentration of teicoplanin in the serum of adults with end stage chronic renal failure undergoing treatment for infection

1 reference

12 December 2020

Serum monitoring of teicoplanin

1 reference

12 December 2020

Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: an open study

1 reference

12 December 2020

Efficacy and pharmacodynamics of teicoplanin given daily during the first 3 days and then on alternate days for methicillin-resistant Staphylococcus aureus infections

1 reference

12 December 2020

Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin

1 reference

12 December 2020

Teicoplanin metabolism in humans

1 reference

12 December 2020

Efficacy, tolerability and pharmacokinetics of teicoplanin in patients undergoing breast surgery

1 reference

12 December 2020

Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis

1 reference

12 December 2020

Teicoplanin concentrations in serum, pericardium, pericardial fluid and thoracic wall fat in patients undergoing cardio-pulmonary bypass surgery

1 reference

12 December 2020

Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration

1 reference

12 December 2020

The quality of clinical serum teicoplanin assays: an experimental European EQA distribution

1 reference

12 December 2020

Comparative safety of teicoplanin and vancomycin

1 reference

12 December 2020

Assay of serum teicoplanin concentrations in clinical specimens: a comparison of isocratic high performance liquid chromatography with polarisation fluoroimmunoassay and bioassay

1 reference

12 December 2020

Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers

1 reference

12 December 2020

Penetration of teicoplanin into heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery

1 reference

12 December 2020

Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1

1 reference

12 December 2020

Pharmacokinetic behavior of intraperitoneal teicoplanin during treatment of peritonitis complicating continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea

1 reference

12 December 2020

Influence of arterio-venous haemofiltration on teicoplanin elimination

1 reference

12 December 2020

Purification of glycopeptide antibiotics by isoelectric focusing in multicompartment electrolyzers with Immobiline membranes

1 reference

12 December 2020

Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients

1 reference

12 December 2020

Pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring of glycopeptides

1 reference

12 December 2020

Pharmacokinetics and Bioavailability of a New Formulation of Teicoplanin following Intravenous and Intramuscular Administration to Humans

1 reference

12 December 2020

Clinical pharmacokinetics of teicoplanin

1 reference

12 December 2020

Performance of a fluorescence polarization immunoassay for teicoplanin in serum.

1 reference

12 December 2020

Stability and compatibility of teicoplanin in parenteral nutrition solutions used in pediatrics

1 reference

12 December 2020

Clinical evaluation of teicoplanin fluorescence polarization immunoassay

1 reference

12 December 2020

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

1 reference

12 December 2020

Teicoplanin versus flucloxacillin in the treatment of infection following burns

1 reference

12 December 2020

The comparative efficacy and safety of teicoplanin and vancomycin

1 reference

12 December 2020

Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis.

1 reference

12 December 2020

A critical review of the dosage of teicoplanin in Europe and the USA.

1 reference

12 December 2020

Factors affecting the normal and branched-chain acyl moieties of teicoplanin components produced by Actinoplanes teichomyceticus

1 reference

12 December 2020

Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses

1 reference

12 December 2020

Pharmacokinetics of a single dose of teicoplanin in burn patients

1 reference

12 December 2020

Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes

1 reference

12 December 2020

10.2165/00003088-200039030-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1014506323

0 references

1 reference